We are international
Donate
• IMF TV TEXT SIZE   
webcasts from medical meetings    back

Dr. Reeder - Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls
Craig B. Reeder, MD
Mayo Clinic
Scottsdale, Arizona
12.23.07

Be the first to comment

 related articles